Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Secretion, degradation, and elimination of glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP) in patients with chronic renal insufficiency and healthy controls
Users are restricted to the pre-determined capsule sizes, which may not always align perfectly with their specific dosage needs
Administration Time Administer peptides at optimal times:- **PT-141:** 45-60 minutes before sexual activity- **Sermorelin:** At bedtime for optimal GH secretion- **GHK-Cu:** Apply morning and night to clean, dry skin or scalp- **NAD+:** Subcutaneous injection 1-3 times per week or oral daily Dosing/Settings Standard dosing protocol:- **PT-141:** 1.0-1.75 mg subcutaneous as needed, max 2x per week- **Sermorelin:** 200-500 mcg subcutaneous daily- **GHK-Cu:** Apply a thin layer to the treatment area twice daily- **NAD+:** 50-500 mg subcutaneous per dose, 1-3x per week Test Spot Requirement Recommended for first-time GHK-Cu users
To evaluate nociceptive behavior, the time spent licking the paw, the paw withdrawal threshold (PWT) to mechanical stimuli, and the PWL to heat were measured as described previously 36
US$ 25.75
US$ 21.01
US$ 27.72
US$ 26.38
